Potential anti-inflammatory, antioxidant and antimicrobial activities of Sambucus australis

Pharm Biol. 2017 Dec;55(1):991-997. doi: 10.1080/13880209.2017.1285324.

Abstract

Context: Sambucus australis Cham. & Schltdl. (Adoxaceae) is used in Brazilian folk medicine to treat inflammatory disorders.

Objective: To evaluate the in vitro anti-inflammatory, antioxidant and antimicrobial properties of S. australis.

Materials and methods: The anti-inflammatory activity of ethanol extracts of the leaf and bark of S. australis (1-100 μg/mL) were studied in lipopolysaccharide/interferon γ stimulated murine macrophages RAW 264.7 cells (24 h incubation) by investigating the release of nitric oxide (NO) and tumour necrosis factor-alpha (TNF-α) and in the TNF-α-induced nuclear factor kappa (NF-κB) assay. Minimum inhibitory concentration (MIC) was determined by the microdilution test (24 h incubation). Antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH), ferric reducing antioxidant power (FRAP) and the NO scavenging assays. Chemical composition was assessed by LC-MS/MS.

Results: Antioxidant activities in the DPPH (IC50 43.5 and 66.2 μg/mL), FRAP (IC50 312.6 and 568.3 μg/mL) and NO radical scavenging assays (IC50 285.0 and 972.6 μg/mL) were observed in the leaf and bark ethanol extracts, respectively. Solely the leaf extract showed significant inhibition of NO and TNF-α production in RAW264.7 cells at concentrations of 2 and 100 μg/mL, respectively, and suppression of TNF-α inhibition of NF-κB by 12.8 and 20.4% at concentrations of 50 and 100 μg/mL, respectively. The extract also exhibited antibacterial activity against Salmonella typhimurium (MIC 250 μg/mL) and Klebsiella pneumoniae (MIC 250 μg/mL). LC-MS/MS revealed the presence of chlorogenic acid and rutin as major compounds.

Discussion and conclusion: The results indicate that the ethanol leaf extract of S. australis exhibit prominent anti-inflammatory effects.

Keywords: Natural products; cytokines; macrophages; nitric oxide; nuclear factor-κB; phenolic compounds.

MeSH terms

  • Animals
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / isolation & purification
  • Anti-Infective Agents / pharmacology*
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / isolation & purification
  • Anti-Inflammatory Agents / pharmacology*
  • Antioxidants / chemistry
  • Antioxidants / isolation & purification
  • Antioxidants / pharmacology*
  • Biphenyl Compounds / chemistry
  • Chlorides / chemistry
  • Chlorogenic Acid / isolation & purification
  • Chlorogenic Acid / pharmacology
  • Dose-Response Relationship, Drug
  • Ethanol / chemistry
  • Ferric Compounds / chemistry
  • HEK293 Cells
  • Humans
  • Inflammation Mediators / metabolism
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / growth & development
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Mice
  • Microbial Sensitivity Tests
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Nitric Oxide / metabolism
  • Oxidation-Reduction
  • Phytotherapy
  • Picrates / chemistry
  • Plant Bark
  • Plant Extracts / chemistry
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Plant Leaves
  • Plants, Medicinal
  • RAW 264.7 Cells
  • Rutin / isolation & purification
  • Rutin / pharmacology
  • Salmonella typhimurium / drug effects*
  • Salmonella typhimurium / growth & development
  • Sambucus / chemistry*
  • Solvents / chemistry
  • Swiss 3T3 Cells
  • Transfection
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anti-Infective Agents
  • Anti-Inflammatory Agents
  • Antioxidants
  • Biphenyl Compounds
  • Chlorides
  • Ferric Compounds
  • Inflammation Mediators
  • Lipopolysaccharides
  • NF-kappa B
  • Picrates
  • Plant Extracts
  • Solvents
  • Tumor Necrosis Factor-alpha
  • Chlorogenic Acid
  • Nitric Oxide
  • Ethanol
  • Rutin
  • 1,1-diphenyl-2-picrylhydrazyl
  • ferric chloride

Grants and funding

The authors are grateful to the Fundação de Amparo à Pesquisa do Espírito Santo (FAPES, grant no. 66606497/2014 and TO 241/2016), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and Conselho Nacional de Desenvolvimento Científico e Tecnológico [CNPq grants n° 401409/2014-7 and n° 443018/2014-6] for the financial support.